JUN 23, 2017 2:48 PM PDT

Novel Retinal Scar ID'ed in Ebola Survivors

WRITTEN BY: Xuan Pham

For people who are lucky enough to survive an Ebola infection, the virus doesn't go away without leaving some traces behind. In particular, scientists found that some Ebola survivors have unique scars in the back of their eyes. Such characteristics could lead to potential diagnostic potential for the disease, as well as lend new insight into the biology of the infection.

Image credit: Wikipedia.org

In January 2016, the World Health Organization (WHO) officially declared the end to the largest Ebola outbreak in history. The outbreak ravaged West Africa in 2014 and 2015, killing over 11,000 people and causing a huge international health crisis.

Despite the high mortality rate associated with the disease, some infected people do recover. And in those who survived, scientists wanted to find out whether Ebola left some visible scars.

The scientists studied a group of 82 Ebola survivors from Sierra Leone. Interestingly, when the team examined the eyes of people in this group, they found signs of scarring at the back of their eyes in about 15 percent of the survivors. By contrast, people who lived in the region but were never infected did not have this unique feature.

The retinal lesion varied among those who had it, but “often [resembled] a diamond or wedge shape,” the scientists wrote. Furthermore, they observed that the scar “appears unique” and “is not characteristic of any other retinal disease.” That is, the scars most likely were caused by Ebola exposure.

The team also observed that the scars were most commonly located next to where nerve fibers connect the eye to the brain. Based on this, they postulate the virus’ route of entry into the eyes had to be along the optic nerve.

The appearance of the retinal scars seemed to be superficial, at least in the short-term. People with the scars seemed to perform equally well on vision acuity tests as people without the scars. However, there’s no guarantee that Ebola exposure doesn’t damage vision in the long-term. So far, previous studies indicate that some Ebola survivors experience eye symptoms, like inflammation and temporary vision loss.

Moreover, some Ebola survivors in the current study had cataracts that could be linked to the virus. Fortunately, when the eye fluids of these patients were analyzed, no trace of the virus were found. This suggest the virus doesn’t linger in eye fluids, and that cataract surgery would be safe for these people.

Of note, the Ebola virus causes severe hemorrhagic fevers, which can often be fatal. The natural reservoir for Ebola is still unknown, but humans can get the virus through direct contact with infected blood or body fluids. People infected with Ebola start showing signs and symptoms from 2 to 21 days after exposure. In the beginning stages, symptoms can be non-specific, including fever, muscle pain, headache, and vomiting. Symptoms of hemorrhagic syndrome occur in the advanced stages of infection. There are yet no licensed vaccines or therapies against this virus.

Additional source: Live Science

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 27, 2019
Immunology
SEP 27, 2019
Diseases We Share with Our Canine Companions: Autoimmune Encephalitis in Dogs
Like humans, dogs can develop autoimmune encephalitis, and it’s common - mostly affecting smaller breeds and young adult dogs. Now scientists underst...
OCT 07, 2019
Clinical & Molecular DX
OCT 07, 2019
The Three Common Herbs Combating High Blood Pressure: Molecular Mechanism Revealed
Hypertension is also known as high blood pressure is a serious condition. According to the Centers for Disease Control and Prevention, about 1 of...
OCT 07, 2019
Genetics & Genomics
OCT 07, 2019
Risk Factors for Gout Revealed by Genome-Wide Association Study
Gout is a common type of arthritis, and causes severe and sudden pain, redness and swelling in the joints....
DEC 04, 2019
Clinical & Molecular DX
DEC 04, 2019
Genetic platform takes the guesswork out of catching infections
A physician is faced with 3 patients: an elderly person with a chronic cough, a child being wheeled out of surgery and a young mother with a high fever. Ho...
JAN 11, 2020
Neuroscience
JAN 11, 2020
Molecular Therapy to Self-Repair Nerve Cells
Neurodegenerative diseases such as Multiple Sclerosis (MS), Alzheimer's, and Huntington's Disease are predicated on damage to myelin on nerve cells...
FEB 15, 2020
Clinical & Molecular DX
FEB 15, 2020
FDA nod for AI-powered technology to detect strokes
The US Food and Drug Administration (FDA) has provided clearance for a novel technology that uses artificial intelligence (AI) to detect strokes. The platf...
Loading Comments...